期刊文献+

呋塞米联合小剂量多巴胺对老年慢性心衰患者BNP的影响 被引量:29

Effect of furosemide combined with low-dose dopamine on brain natriuretic peptide in elderly patients with chronic heart failure
下载PDF
导出
摘要 目的探讨呋塞米联合小剂量多巴胺治疗老年慢性心力衰竭(CHF)的临床疗效及对血浆脑钠肽(BNP)等的影响。方法 2015年1月至2016年12月期间铜陵市人民医院心内科住院的60例老年CHF患者按随机数表法分为观察组(n=30)和对照组(n=30)。对照组在常规抗心衰基础上静脉注射呋塞米,观察组在对照组基础上再加用小剂量多巴胺治疗。评估两组治疗疗效,分析治疗前后血浆BNP等生化指标和超声心动图检查结果。结果观察组患者的治疗总有效率[93.33%(28/30]明显高于对照组[76.67%(23/30)],差异有统计学意义(P<0.05);两组患者治疗前血浆BNP、C反应蛋白(CRP)水平、呼吸、全身症状程度比较差异均无统计学意义(P>0.05),治疗后两组BNP、CRP、呼吸、全身症状程度均明显改善,与治疗前比较差异均有统计学意义(P<0.05);治疗后观察组患者的BNP、CRP分别为(143.18±31.32)pg/mL、(5.44±1.12)mg/L,明显低于对照组的(180.14±25.10)pg/mL、(7.32±1.23)mg/L,差异均有统计学意义(P<0.05);观察组患者的呼吸困难、肺部啰音、水肿、乏力程度分别为(1.28±0.40)分、(1.19±0.31)分、(1.02±0.19)分、(1.21±0.22)分,明显低于对照组的(1.89±0.39)分、(1.79±0.31)分、(1.54±0.27)分、(1.61±0.24)分,差异均有统计学意义(P<0.05);观察组治疗后活动后无胸闷气促、心绞痛发生率为6.67%(2/30)、3.33%(1/30),明显低于对照组的26.67%(8/30)、20.00%(6/30),差异均有统计学意义(P<0.05)。结论呋塞米联合小剂量多巴胺可显著提高老年CHF的临床疗效,有效改善心功能与BNP水平,并可降低不良事件发生风险。 Objective To investigate the clinical effect of furosemide combined with low-dose dopamine in the treatment of elderly patients with chronic heart failure(CHF) and the effect on brain natriuretic peptide(BNP). Methods Sixty elderly patients with CHF who admitted to Department of Cardiology in our hospital from January 2015 to December 2016 were rand omly divided into observation group(n=30) and control group(n=30) according to the rand om number table. The control group received intravenous injection of furosemide on the basis of conventional anti-heart failure, and the observation group was treated with small doses of dopamine on the basis of the control group. The therapeutic effects between the two groups were evaluated. The biochemical indexes such as plasma BNP and results of echocardiography were analyzed before and after treatment. Results The to tal effective rate of treatment was significantly higher in the observation group than the control group, 93.33% (28/30) vs 76.67% (23/30), P〈0.05. Before treatment, there were no significant difference between the two groups in levels of plasma BNP and C reactive protein(CRP), respiration and degree of systemic symptoms(P〈0.05). After treatment, the above indexes were significantly improved compared with before treatment(P〈0.05). After treatment, the levels of BNP, CRP, scores of dyspnea, pulmonary rales, edema, fatigue in observation group were(143.18 ± 31.32) pg/mL,(5.44±1.12) mg/L,(1.28±0.40),(1.19±0.31),(1.02±0.19),(1.21±0.22), significantly lower than(180.14±25.10) pg/mL,(7.32±1.23) mg/L,(1.89±0.39),(1.79±0.31),(1.54±0.27),(1.61±0.24) in the control group(P〈0.05). The incidence rates of shortness of breath without chest pain, angina were 6.67% (2/30), 3.33% (1/30) in observation group after treatment,which were significantly lower than 26.67% (8/30), 20.00% (6/30) in the control group(P〈0.05). Conclusion Furosemide combined with low-dose dopamine can improve the efficacy of treating elderly patients with CHF, which can effectively improve cardiac function and BNP level, and reduce the risk of adverse events.
作者 吴昊
出处 《海南医学》 CAS 2017年第15期2440-2443,共4页 Hainan Medical Journal
关键词 老年 慢性心力衰竭 呋塞米 小剂量 多巴胺 脑钠肽 Elderly Chronic heart failure(CHF) Furosemide Low-dose Dopamine Brain natriuretic peptide(BNP)
  • 相关文献

参考文献10

二级参考文献80

  • 1王瑞,刘红艳.左卡尼汀对血液透析患者心功能及血脂的影响[J].临床内科杂志,2007,24(9):628-630. 被引量:10
  • 2Troosters T, Gnsselink R, Decmmer M. Six minute walking distance in healthy elderly subjects[ J]. Eur Respir J, 1999 ; 14:270 - 274.
  • 3Maisol A. B -type natriuretic peptide levels:diagnostic and prognos- tic in congestive heart failure : what" s next [ J ]. Circulation, 2002 ; 105:2328 - 2331.
  • 4M Calvani, E Reda, E Arigoni-Martelli. Regulation by" carnitine of myocardial fatty acid and carbohydrate me- tabolism under normal and pathological conditions[J]. Basic research in cardiology, 2000,92 (2) : 75-83.
  • 5张月宁.佑安住院医师手册[M].北京:中国协和医科大学出版社,2012: 58-60.
  • 6跃进,华伟.阜外心血管内科手册[M].北京:人民卫生出版社,2006:212-225.
  • 7医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007, 35(6): 1076-1095.
  • 8Mokhles MM, Trifiro G., Dieleman JP, et al. The risk of new onsetheart failure associated with dopamine agonist use in Parkinson'sdisease [J]. Pharmacological research, 2012,65(3): 358-364.
  • 9Rokutan H, Suckow C, VonHaehling S, et al. Furosemide inducesmortality in a rat model of chronic heart failure [J]. InternationalJournal of Cardiology, 2012,160(1): 20-25.
  • 10Tuttolomondo A, Pinto A, Parrinello G, et al. Intravenous high-dosefurosemide and hypertonic saline solutions for refractory heart fail-ure and ascites [J]. Seminars inNq)hrology, 2011, 31(6): 513-522.

共引文献196

同被引文献226

引证文献29

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部